Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Stent con liberación de fármaco")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 876

  • Page / 36
Export

Selection :

  • and

Update on drug-eluting stents : as good as it gets?JAIN, Ajay K; MATHUR, Anthony.Clinical medicine. 2007, Vol 7, Num 4, pp 401-404, issn 1470-2118, 4 p.Article

XTENT® Custom NX™ drug eluting stent systemsEVANS, Laura Wilkes; DORAN, Paula; MARCO, Philippe et al.EuroIntervention. 2007, Vol 3, Num 1, pp 158-161, issn 1774-024X, 4 p.Article

Current Status of Drug Eluting StentsKIPSHIDZE, Nicholas.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, issn 1381-6128, 96 p.Serial Issue

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsMAURI, Laura; KEREIAKES, Dean J; HOLMES, David R et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

AXXESS™ Biolimus A9® eluting bifurcation stent systemVERHEYE, Stefan; TRAUTHEN, Brett.EuroIntervention. 2007, Vol 2, Num 4, pp 506-508, issn 1774-024X, 3 p.Article

Les stents coronaires à élution sont-ils dangereux? : Cardiologie = Are drug-eluting stents dangerous ?DE BENEDETTI, Edoardo; URBAN, Philip.Revue médicale suisse. 2007, Vol 3, Num 102, pp 656-658, issn 1660-9379, 3 p.Article

Health economics : drug-eluting stents -are they worth the money?GERSHLICK, Anthony H; FEARN, Steve.EuroIntervention. 2008, Vol 4, issn 1774-024X, C75-C79, SUPCArticle

Current Status of Drug-Eluting StentsRABER, Lorenz; WINDECKER, Stephan.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 176-189, issn 1755-5914, 14 p.Article

Drug-eluting/biodegradable stentsGastrointestinal endoscopy (Print). 2011, Vol 74, Num 5, pp 954-958, issn 0016-5107, 5 p.Article

In-Stent RestenosisKIM, Michael S; DEAN, Larry S.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 190-198, issn 1755-5914, 9 p.Article

Impact of late drug-eluting stent malapposition on 3-year clinical eventsHONG, Myeong-Ki; MINTZ, Gary S; PARK, Seong-Wook et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 15, pp 1515-1516, issn 0735-1097, 2 p.Article

Are Surrogate End Points in Drug-Eluting Stent Trials Reliable? Authors' replyAGOSTONI, Pierfrancesco; BIONDI-ZOCCAI, Giuseppe G. L; POCOCK, Stuart J et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 20, pp 1991-1992, issn 0735-1097, 2 p.Article

Drug-Eluting Stents and Antiplatelet ResistanceSIMON, Daniel I; JOZIC, Joseph.The American journal of cardiology. 2008, Vol 102, Num 9, issn 0002-9149, 29J-37J, SUPConference Paper

Use of drug-eluting stents in Victorian public hospitalsYAN, Bryan P; AJANI, Andrew E; SEBASTIAN, Martin et al.Medical journal of Australia. 2006, Vol 185, Num 7, pp 363-367, issn 0025-729X, 5 p.Article

NICE guidelines for the use of drug-eluting stents : how do we establish worth? CommentaryDE BELDER, M. A; PFISTERER, Matthias E; RICHARDSON, J et al.Heart (London 1996). 2008, Vol 94, Num 12, pp 1646-1652, issn 1355-6037, 7 p.Article

Drug-Eluting Coronary-Artery StentsSTEFANINI, Giulio G; HOLMES, David R.The New England journal of medicine. 2013, Vol 368, Num 3, pp 254-265, issn 0028-4793, 12 p.Article

Intrepide™; Trapidil Eluting StentKHAN, Mazhar; NI MHULLAIN, Fiona; NOLAN, Margaret et al.EuroIntervention. 2008, Vol 4, Num 3, pp 405-411, issn 1774-024X, 7 p.Article

In-Stent Restenosis in the Drug-Eluting Stent EraDANGAS, George D; CLAESSEN, Bimmer E; CAIXETA, Adriano et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 23, pp 1897-1907, issn 0735-1097, 11 p.Article

Three aneurysms developed in three different drug-eluting stentsLEE, Young-Soo; KIM, Kee-Sik; CHANG, Sung-Gug et al.European heart journal. 2009, Vol 30, Num 11, issn 0195-668X, p. 1309Article

A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label IndicationsMARROQUIN, Oscar C; SELZER, Faith; SMITH, Conrad et al.The New England journal of medicine. 2008, Vol 358, Num 4, pp 342-352, issn 0028-4793, 11 p.Article

Four-Year Clinical Follow-Up of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital RegistryDAEMEN, Joost; KUKREJA, Neville; VAN TWISK, Piet-Hein et al.The American journal of cardiology. 2008, Vol 101, Num 8, pp 1105-1111, issn 0002-9149, 7 p.Article

Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stentsBURZOTTA, Francesco; SIVIGLIA, Massimo; BIONDI-ZOCCAI, Giuseppe et al.The American journal of cardiology. 2007, Vol 99, Num 3, pp 364-368, issn 0002-9149, 5 p.Article

Repeated drug-eluting stent implantation for drug-eluting stent restenosis : The same or a different stentCOSGRAVE, John; MELZI, Gloria; CARLINO, Mauro et al.The American heart journal. 2007, Vol 153, Num 3, pp 354-359, issn 0002-8703, 6 p.Article

Biodegradable drug eluting stents : invasive and non-invasive imagingKUKREJA, Neville; OTSUKA, Masato; VAN MIEGHEM, Carlos et al.EuroIntervention. 2006, Vol 2, Num 3, pp 403-403, issn 1774-024X, 1 p.Article

Everolimus eluting stents : beyond targeting restenosis!FLAN, Aloke V; NAKAZAWA, Gaku; JONER, Michael et al.EuroIntervention. 2006, Vol 2, Num 3, pp 277-279, issn 1774-024X, 3 p.Article

  • Page / 36